Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Grabowski

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Social Science & Medicine (1982)|August 1, 1997
The impact of cost-effectiveness on public and private policies in health care: an international perspective. Introduction and overviewF A Sloan, H G Grabowski
Blood|July 1, 1997
Enzyme therapy in Gaucher disease type 1: effect of neutralizing antibodies to acid beta-glucosidaseE Ponce, J Moskovitz, G Grabowski
Clinical Pharmacology and Therapeutics|October 24, 2007
Should the patent system for new medicines be abolished?J A DiMasi, H G Grabowski
Journal of Health Economics|November 4, 1994
Returns to R&D on new drug introductions in the 1980sH G Grabowski, J M Vernon
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Impact of economic, regulatory, and patent policies on innovation in cancer chemopreventionHenry G Grabowski, Jeffrey L Moe
Talanta|April 1, 1995
The trifluoroacetic anhydride-sodium iodide system as a reagent for determination and microdetermination of nitroxide radicalsW Ciesielski, Z H Kudzin, G Grabowski
Health Affairs (Project Hope)|June 4, 2014
Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near futureHenry G Grabowski, Rahul Guha, Maria Salgado
Aviation, Space, and Environmental Medicine|November 30, 2005
Ground crew injuries and fatalities in U.S. commercial aviation, 1983-2004Jurek G Grabowski, Susan P Baker, Guohua Li
Health Affairs (Project Hope)|February 4, 2015
The roles of patents and research and development incentives in biopharmaceutical innovationHenry G Grabowski, Joseph A DiMasi, Genia Long
Health Affairs (Project Hope)|March 9, 2006
Developing drugs for developing countriesDavid B Ridley, Henry G Grabowski, Jeffrey L Moe
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Social Science & Medicine (1982)|August 1, 1997
The impact of cost-effectiveness on public and private policies in health care: an international perspective. Introduction and overviewF A Sloan, H G Grabowski
Blood|July 1, 1997
Enzyme therapy in Gaucher disease type 1: effect of neutralizing antibodies to acid beta-glucosidaseE Ponce, J Moskovitz, G Grabowski
Clinical Pharmacology and Therapeutics|October 24, 2007
Should the patent system for new medicines be abolished?J A DiMasi, H G Grabowski
Journal of Health Economics|November 4, 1994
Returns to R&D on new drug introductions in the 1980sH G Grabowski, J M Vernon
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Impact of economic, regulatory, and patent policies on innovation in cancer chemopreventionHenry G Grabowski, Jeffrey L Moe
Talanta|April 1, 1995
The trifluoroacetic anhydride-sodium iodide system as a reagent for determination and microdetermination of nitroxide radicalsW Ciesielski, Z H Kudzin, G Grabowski
Health Affairs (Project Hope)|June 4, 2014
Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near futureHenry G Grabowski, Rahul Guha, Maria Salgado
Aviation, Space, and Environmental Medicine|November 30, 2005
Ground crew injuries and fatalities in U.S. commercial aviation, 1983-2004Jurek G Grabowski, Susan P Baker, Guohua Li
Health Affairs (Project Hope)|February 4, 2015
The roles of patents and research and development incentives in biopharmaceutical innovationHenry G Grabowski, Joseph A DiMasi, Genia Long
Health Affairs (Project Hope)|March 9, 2006
Developing drugs for developing countriesDavid B Ridley, Henry G Grabowski, Jeffrey L Moe
Pageof 8